Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe
09:02am, Thursday, 26'th Jan 2023
Despite being one of the few authorized COVID-19 vaccine makers in the United States, Novavax's (NVAX) vaccine struggles for market share.
This Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year
07:15am, Wednesday, 25'th Jan 2023
If you want to invest in volatile stocks, a certain strategy can minimize your overall risk.
3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023
05:06am, Tuesday, 24'th Jan 2023
Exceptionally high short interest in these innovative and transformative businesses may lead to a short squeeze.
Could Novavax Stock Help You Become a Millionaire?
08:43am, Friday, 20'th Jan 2023
At such a beaten-down valuation, is the upside for Novavax just too significant to ignore?
Here's the Worst Mistake Novavax Investors Can Make in 2023
06:30am, Friday, 20'th Jan 2023
Can Novavax still win over the long term?
Novavax (NVAX) Gets Nod for COVID-19 Booster Jab in South Korea
12:02pm, Thursday, 19'th Jan 2023
Novavax's (NVAX) COVID-19 vaccine gets approval in South Korea as a booster dose in adults 18 years and older.
3 Biotech Stocks Under $15 Worth a Second Look in 2023
08:00am, Wednesday, 18'th Jan 2023
All three stocks have promising therapies that could drive revenue in the coming years.
2 Down-on-Their-Luck Stocks That Could Go Parabolic
02:00pm, Tuesday, 17'th Jan 2023
Any bit of good news could send these stocks soaring.
Novavax CEO reflects on COVID-19, company milestones, and his retirement
12:00am, Saturday, 14'th Jan 2023
This segment originally aired on January 10, 2023. Novavax CEO Stanley Erck spoke with Yahoo Finance health care reporter Anjalee Khemlani at the 2023 JPMorgan Healthcare Conference about the impact o
Don't Blame the Bear Market for This Growth Stock's Jaw-Dropping Sell-Off
10:00am, Thursday, 12'th Jan 2023
Novavax stock would likely have fallen in 2022 even in a bull market.
With This Big Transition Ahead, Is Novavax a Buy?
06:00am, Thursday, 12'th Jan 2023
Novavax stock sank 92% last year.
Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money in 18 Months
05:06am, Wednesday, 11'th Jan 2023
These innovative growth stocks have the tailwinds necessary to deliver triple-digit returns for their shareholders by mid-2024.
Novavax (NVAX) Names John Jacobs as New CEO, Shares Rise
12:47pm, Tuesday, 10'th Jan 2023
Novavax (NVAX) appoints John C. Jacobs as its new president and chief executive officer, effective Jan 23, 2023.
Novavax: John Jacobs to succeed Stanley Erck as CEO
03:27pm, Monday, 09'th Jan 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss John Jacobs replacing Stanley Erck as Novavax CEO.
NVAX Stock Alert: What to Know as Novavax Names New CEO
01:37pm, Monday, 09'th Jan 2023
After struggling mightily since the tail end of 2021, Novavax (NASDAQ: NVAX ) finally gave embattled stakeholders something to cheer about. On Monday, NVAX stock popped dramatically higher on the news
